Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Filing of the 2014 Registration document



Avignon, May 4th 2015 - Naturex, world leader in speciality plant-based ingredients, has published its registration document for the year ended December 31st, 2014.



  • 2014 Registration document

The 2014 Registration document was filed with the French Financial Markets Authority (Autorité des Marchés Financiers) on April 30th, 2015 under the number D.15-0452.


This document includes :



  • the annual financial report for the year ended December 31st, 2014 according to article L 451-1-2 of Code monétaire et financier ;

  • the Chairman of the Board of Directors' Report on Corporate Governance, internal control and risk management ;

  • the report relating to the social, environmental and societal informations ;

  • the information related to the Statutory Auditors'fees.

Copies of this document in French language are available free of charge, pursuant to applicable law, and can be downloaded from the company's web site www.naturex.fr, under the « Finance - Documents and Publications » section, as well as on www.amf-france.org.

English translation of this document will be soon available.


 


You can receive all financial information of Naturex free of charge by signing up at: www.naturex.com


 



  • Financial schedule







    Q1 2015 results: 26 May 2015



  • Upcoming events











    - AGM (Paris) 24 June 2015
    - Strategy 2020 Presentation (Paris) 30 June 2015


 


Naturex has been listed since October 1996 on Euronext in Paris, Segment B








NATUREX Total number of shares comprising the share capital: 9,205,153 (March 2015)

ISIN FR0000054694



NATUREX is a component of the CACT, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa Index.

Naturex is eligible for the "long only" Deferred Settlement Service (SRD) and French equity plans (PEA and PEA-PME).

Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.



TICKER: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR SYMBOL: NTUXY

 


About Naturex


Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (Food & Beverage, Nutrition & Health and Personal Care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.


Naturex's head office is based in Avignon. The company employs 1,600 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 16 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.



  • Contacts







Carole Alexandre

Investor Relations

Tel.: +33 (0)4 90 23 78 28

[email protected]
Anne Catherine Bonjour

Actus Finance Press Relations

Tel.: +33 (0)1 53 67 36 93

[email protected]

Information réglementée
Communiqués de mise à disposition de documents :

- Modalités de mise à disposition de document de référence ou de ses actualisations

Full and original press release in PDF:


http://www.actusnews.com/documents_communiques/ACTUS-0-39826-cp_naturex-040515.pdf

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free



Quelle: Actusnews

Like: 0
Teilen

Kommentare